Related content

The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs

By Taylor Holly A.   Kuwana Ellen   Wilfond Benjamin S.  

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 51-51

Routledge Ltd

Access to resources Recommend Favorite

The Relevance of Research Study Phase to Disclosure of Off-Label Drug Availability

By Baskaran Amrutha   Sade Robert M.  

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 53-54

Routledge Ltd

Access to resources Recommend Favorite

Is There an Ethical Obligation to Disclose Controversial Risk? A Question From the ACCORD Trial

By DeMarco Joseph P.   Ford Paul J.   Patton Dana J.   Stewart Douglas O.  

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 4-10

Routledge Ltd

Access to resources Recommend Favorite

Do Researchers Have an Obligation to Actively Look for Genetic Incidental Findings?

By Gliwa Catherine   Berkman Benjamin E.  

American Journal of Bioethics, Vol. 13, Iss. 2, 2013-02 ,pp. : 32-42

Routledge Ltd

Access to resources Recommend Favorite

Should Researchers Disclose Results to Descendants?

By Rothstein Mark A.  

American Journal of Bioethics, Vol. 13, Iss. 10, 2013-10 ,pp. : 64-65

Routledge Ltd

Access to resources Recommend Favorite